Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cutler

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Communications in Psychopharmacology|January 1, 1979
Apomorphine hypothermia: an index of central dopamine receptor function in manN R Cutler, R M Post, W E Bunney
The Annals of Pharmacotherapy|February 26, 1998
Potential for adverse events in patients with generalized anxiety disorderE J Frackiewicz-Koziol, J J Sramek, N R Cutler
Expert Opinion on Investigational Drugs|April 3, 2001
Beta-amyloid therapies in Alzheimer's diseaseS Jhee, T Shiovitz, A W Crawford, et al.
Biological Psychiatry|April 1, 1983
Temporal association between depression-dependent dyskinesias and high urinary phenylethylamine outputM Linnoila, F Karoum, N R Cutler, et al.
Life Sciences|April 21, 1999
NXX-066 in patients with Alzheimer's disease: a bridging studyJ J Sramek, J Hourani, S S Jhee, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorderJ J Sramek, R E Robinson, A Suri, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Salicylate protein binding in serum from young and elderly subjects as measured by diafiltrationL J Lesko, P K Narang, L Yeager, et al.
Biological Psychiatry|September 1, 1983
Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disordersD V Jeste, N R Cutler, C A Kaufmann, et al.
Clinical Pharmacokinetics|May 1, 2001
Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative reviewS S Jhee, T Shiovitz, A W Crawford, et al.
Life Sciences|March 1, 1982
Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patientsN R Cutler, D V Jeste, F Karoum, et al.
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Communications in Psychopharmacology|January 1, 1979
Apomorphine hypothermia: an index of central dopamine receptor function in manN R Cutler, R M Post, W E Bunney
The Annals of Pharmacotherapy|February 26, 1998
Potential for adverse events in patients with generalized anxiety disorderE J Frackiewicz-Koziol, J J Sramek, N R Cutler
Expert Opinion on Investigational Drugs|April 3, 2001
Beta-amyloid therapies in Alzheimer's diseaseS Jhee, T Shiovitz, A W Crawford, et al.
Biological Psychiatry|April 1, 1983
Temporal association between depression-dependent dyskinesias and high urinary phenylethylamine outputM Linnoila, F Karoum, N R Cutler, et al.
Life Sciences|April 21, 1999
NXX-066 in patients with Alzheimer's disease: a bridging studyJ J Sramek, J Hourani, S S Jhee, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorderJ J Sramek, R E Robinson, A Suri, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Salicylate protein binding in serum from young and elderly subjects as measured by diafiltrationL J Lesko, P K Narang, L Yeager, et al.
Biological Psychiatry|September 1, 1983
Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disordersD V Jeste, N R Cutler, C A Kaufmann, et al.
Clinical Pharmacokinetics|May 1, 2001
Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative reviewS S Jhee, T Shiovitz, A W Crawford, et al.
Life Sciences|March 1, 1982
Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patientsN R Cutler, D V Jeste, F Karoum, et al.
Pageof 17